(Q40925166)

24 September 2017

1 reference

title

Breast cancer immunotherapy: current status and future prospects (English)

1 reference

24 September 2017

1 reference

Apostolopoulos V

1

1 reference

24 September 2017

McKenzie IF

series ordinal

2

1 reference

24 September 2017

Pietersz GA

series ordinal

3

1 reference

24 September 2017

language of work or name

1 reference

1 October 1996

1 reference

Immunology & Cell Biology

24 September 2017

published in

1 reference

24 September 2017

volume

74

1 reference

24 September 2017

issue

5

1 reference

24 September 2017

page(s)

457-464

1 reference

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

21 January 2018

Epithelial mucin genes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

Vaccination against tumor cells expressing breast cancer epithelial tumor antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

Structurally defined synthetic cancer vaccines: analysis of structure, glycosylation and recognition of cancer associated mucin, MUC-1 derived peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

Immune response to chemically modified flagellin. I. Induction of antibody tolerance to flagellin by acetoacetylated derivatives of the protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

Monoclonal antibodies reactive with mucin expressed in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

7 January 2021

Second-generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

7 January 2021

Detection of a circulating antibody against a peptide epitope on a mucin core protein, MUC1, in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

7 January 2021

The polymorphic epithelial mucin as a target for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

7 January 2021

Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

7 January 2021

Galactose oxidation in the design of immunogenic vaccines

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.76

7 January 2021

Identifiers

DOI

10.1038/ICB.1996.76

1 reference

24 September 2017

1 reference